by James Smith | Dec 9, 2014
. With contributions from David Brindley. Suppose you are a talented fisherman and an outstanding shoe-maker. You have abandoned your dreams of a career in the regenerative medicine industry because, in one day, you can catch 100 fish or make one complete pair of...
by Mark Curtis | Dec 4, 2014
. The Edmonton Protocol for the transplantation of insulin producing cells into individuals with type 1 diabetes (T1DM) has a cost per quality-adjusted life year (QALY) of ~$165,000. This is more than three times the willingness-to-pay (WTP) in Canada, and comfortably...
by Mark Curtis | Nov 27, 2014
. Welcome to your Update from the Clinic for the month of October. Northwest Biotherapeutics continues to receive support for its cancer vaccine platform in Europe. Neuralstem and StemCells provided updates on their respective clinical programs for spinal cord injury....
by Mark Curtis | Nov 20, 2014
. You have all by now heard that Dendreon has filed for bankruptcy protection. If you’re a regular reader of Signals, you may have first heard the news here. While the company has successfully reached agreements on a financial restructuring with a majority of its...
by David Brindley | Nov 19, 2014
. With contributions from James Smith, a recent Oxford University graduate and current CASMI Translational Stem Cell Consortium Research Associate. Both the IBC Cell Therapy Bioprocessing (ICTB) conference and the Stem Cells and Regenerative Medicine Congress...
by Stacey Johnson | Nov 14, 2014
. The month of November can mean different things to different people. For example, Canadians recognize Remembrance Day on November 11, Americans have Veterans Day and my Polish friends celebrate National Independence Day. There’s American Thanksgiving immediately...
Comments